Open Access
Standardized seed extract of Cajanus cajan (L) Millsp. produced antinociceptive and anti-inflammatory actions through inhibition of inflammatory mediators and activation of opioidergic signaling
Taiwo G. Olubodun-Obadun
1, 2
,
Ismail O. Ishola
1, 2
,
Chisom A. Osumuo
2
,
Olufunmilayo O. Adeyemi
1, 2
Publication type: Journal Article
Publication date: 2023-11-01
Complementary and alternative medicine
General Pharmacology, Toxicology and Pharmaceutics
Abstract
Peripheral tissue damage and diseases could lead to persistent pain beyond possible resolution suggestive of disease-promoting condition which gives rise to chronic pain. The inability of current medications to manage some chronic inflammatory and painful conditions necessitate the need for better treatment options. Natural products have been a veritable source for the discovery of more efficacious and safer therapeutics. Cajanus cajan (L) Millsp, (Fabaceae) is used in traditional African medicines for the treatment of painful, gut disturbance and inflammatory conditions. Hence, the current study aims to investigate the anti-inflammatory and antinociceptive actions of the ethanol seed extract of Cajanus cajan (CC) in rodents and possible mechanisms of action. High performance liquid chromatography coupled with diode-array detection (HPLC-DAD) was used to identify 8 major flavonoids in CC. Antinociceptive activity was investigated using the acetic acid-induced writhing reflex, biphasic formalin-induced flinching behaviour and supraspinal hot plate-evoked nociception in mice. Carrageenan-induced rat paw oedema test was used to evaluate the anti-inflammatory action of CC in rats. Possible mechanism of antinociception and anti-inflammatory actions were examined using both in vivo model and molecular docking procedures against µ-opioid receptor (MOR), cyclooxygenase-2 (COX-2) and phospholipase A2 (PLA2) proteins, respectively. The chromatographic procedure qualitatively and quantitatively confirmed the presence of rutin, quercetin, gallic acid, luteolin, pinostrobin, BiochaninA, formononetin and apigenin in CC. The in vivo nociceptive assay, showed that CC (50, 100, or 200mg/kg, p.o.) significantly decreased mean number of writhing reflex with peak effect at 50mg/kg (72% inhibition) when compared with vehicle control in mouse writhing test. Similarly, the biphasic formalin-induced nociception was significantly reduced by CC (50mg/kg) with 24.61 and 66.73% inhibition of nociceptive reactions in both the early and late phases of formalin-induced inflammatory pain, respectively. In addition, CC significantly increased supraspinal thermally mediated pain threshold with maximum possible effects of 42.25 and 52.16% at CC 50 and 100mg/kg, respectively, in hot-plate test. Similarly, CC100mg/kg caused time course inhibition of carrageenan-induced paw oedema in rat with peak effect (65.78%, CC 100mg/kg; 6h). Interestingly, the antinociceptive action of CC was blocked by the pre-treatment of mice with L-NG-nitro arginine methyl ester (L-NAME) or naloxone. The molecular docking analysis revealed prominent interactions of pinostrobin, physcion and lupeol with MOR, COX-2, and PLA2, respectively. Findings from this study showed that Cajanus cajan seeds extract possesses anti-nociceptive and anti-inflammatory through inhibition of inflammatory mediators (PLA2/COX-2) and activation of opioidergic signaling.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
|
|
|
Journal of Ethnopharmacology
1 publication, 33.33%
|
|
|
Frontiers in Pharmacology
1 publication, 33.33%
|
|
|
Botany Letters
1 publication, 33.33%
|
|
|
1
|
Publishers
|
1
|
|
|
Elsevier
1 publication, 33.33%
|
|
|
Frontiers Media S.A.
1 publication, 33.33%
|
|
|
Taylor & Francis
1 publication, 33.33%
|
|
|
1
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
3
Total citations:
3
Citations from 2024:
3
(100%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Olubodun-Obadun T. G. et al. Standardized seed extract of Cajanus cajan (L) Millsp. produced antinociceptive and anti-inflammatory actions through inhibition of inflammatory mediators and activation of opioidergic signaling // Phytomedicine Plus. 2023. Vol. 3. No. 4. p. 100483.
GOST all authors (up to 50)
Copy
Olubodun-Obadun T. G., Ishola I. O., Osumuo C. A., Adeyemi O. O. Standardized seed extract of Cajanus cajan (L) Millsp. produced antinociceptive and anti-inflammatory actions through inhibition of inflammatory mediators and activation of opioidergic signaling // Phytomedicine Plus. 2023. Vol. 3. No. 4. p. 100483.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/j.phyplu.2023.100483
UR - https://doi.org/10.1016/j.phyplu.2023.100483
TI - Standardized seed extract of Cajanus cajan (L) Millsp. produced antinociceptive and anti-inflammatory actions through inhibition of inflammatory mediators and activation of opioidergic signaling
T2 - Phytomedicine Plus
AU - Olubodun-Obadun, Taiwo G.
AU - Ishola, Ismail O.
AU - Osumuo, Chisom A.
AU - Adeyemi, Olufunmilayo O.
PY - 2023
DA - 2023/11/01
PB - Elsevier
SP - 100483
IS - 4
VL - 3
SN - 2667-0313
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2023_Olubodun-Obadun,
author = {Taiwo G. Olubodun-Obadun and Ismail O. Ishola and Chisom A. Osumuo and Olufunmilayo O. Adeyemi},
title = {Standardized seed extract of Cajanus cajan (L) Millsp. produced antinociceptive and anti-inflammatory actions through inhibition of inflammatory mediators and activation of opioidergic signaling},
journal = {Phytomedicine Plus},
year = {2023},
volume = {3},
publisher = {Elsevier},
month = {nov},
url = {https://doi.org/10.1016/j.phyplu.2023.100483},
number = {4},
pages = {100483},
doi = {10.1016/j.phyplu.2023.100483}
}
Cite this
MLA
Copy
Olubodun-Obadun, Taiwo G., et al. “Standardized seed extract of Cajanus cajan (L) Millsp. produced antinociceptive and anti-inflammatory actions through inhibition of inflammatory mediators and activation of opioidergic signaling.” Phytomedicine Plus, vol. 3, no. 4, Nov. 2023, p. 100483. https://doi.org/10.1016/j.phyplu.2023.100483.